Gwenn Hansen
Patrimonio netto: 3 M $ in data 31/08/2026
Patrimonio netto: 3 M $ in data 31/08/2026
Gwenn M.
Hansen is Chief Scientific Officer at Nurix Therapeutics, Inc. since 2020, with employment at the company starting in 2015.
Formerly, served as Associate Professor at Baylor College of Medicine.
Education includes undergraduate studies at Gustavus Adolphus College and a doctorate from the University of Tennessee.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/09/2026 | 117.227 ( 0,11% ) | 3 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2019 |
| Società | Posizione | Fine |
|---|---|---|
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Gustavus Adolphus College
Gustavus Adolphus College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale